$7.02
1.45%
Nasdaq, Sep 02, 10:00 pm CET
ISIN
IL0010941198
Symbol
KMDA

Kamada Ltd Stock price

$7.02
-0.17 2.36% 1M
+0.42 6.35% 6M
+1.10 18.57% YTD
+1.43 25.59% 1Y
+2.31 48.89% 3Y
-2.11 23.10% 5Y
+3.61 105.73% 10Y
-0.28 3.84% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
+0.10 1.45%
ISIN
IL0010941198
Symbol
KMDA
Industry

Key metrics

Basic
Market capitalization
$403.7m
Enterprise Value
$349.1m
Net debt
positive
Cash
$66.0m
Shares outstanding
57.5m
Valuation (TTM | estimate)
P/E
21.3 | 19.7
P/S
2.4 | 2.2
EV/Sales
2.1 | 1.9
EV/FCF
11.1
P/B
1.6
Financial Health
Equity Ratio
69.7%
Return on Equity
5.6%
ROCE
7.8%
ROIC
9.9%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$169.5m | $184.3m
EBITDA
$39.9m | $42.7m
EBIT
$25.2m | $26.5m
Net Income
$19.0m | $20.5m
Free Cash Flow
$31.6m
Growth (TTM | estimate)
Revenue
9.7% | 14.5%
EBITDA
34.6% | 94.7%
EBIT
50.0% | 32.3%
Net Income
26.1% | 42.0%
Free Cash Flow
189.0%
Margin (TTM | estimate)
Gross
43.6%
EBITDA
23.6% | 23.2%
EBIT
14.9%
Net
11.2% | 11.1%
Free Cash Flow
18.6%
More
EPS
$0.3
FCF per Share
$0.5
Short interest
0.2%
Employees
420
Rev per Employee
$380.0k
Show more

Is Kamada Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Kamada Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Kamada Ltd forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Kamada Ltd forecast:

Buy
89%
Hold
11%

Financial data from Kamada Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
170 170
10% 10%
100%
- Direct Costs 96 96
7% 7%
56%
74 74
14% 14%
44%
- Selling and Administrative Expenses 35 35
8% 8%
20%
- Research and Development Expense 14 14
13% 13%
8%
40 40
35% 35%
24%
- Depreciation and Amortization 15 15
14% 14%
9%
EBIT (Operating Income) EBIT 25 25
50% 50%
15%
Net Profit 19 19
26% 26%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Kamada Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kamada Ltd Stock News

Positive
Seeking Alpha
6 days ago
KMDA remains a buy as it delivers strong earnings growth, robust cash generation, and trades at a discount to healthcare peers with an attractive FCF yield. Q2 results confirm ongoing operating leverage, with each $1 in new sales producing $3-$5 in incremental operating profit and EBITDA margins above industry averages. Strategic growth pillars—organic expansion and infrastructure investment, i...
Neutral
Seeking Alpha
20 days ago
Kamada Ltd. (NASDAQ:KMDA ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call Participants Annabel Eva Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division James Philip Sidoti - Sidoti & Company, LLC Brian Ritchie - Lifesci Advisors, LLC Operator Greetings, ...
Neutral
GlobeNewsWire
28 days ago
REHOVOT, Israel, and HOBOKEN, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd.
More Kamada Ltd News

Company Profile

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Mr. London
Employees 420
Founded 1990
Website www.kamada.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today